VIVO News and Press, Meridian Bioscience Inc. From 06/30/22

We conclude our roundtable series with Biotech and Healthcare coverage. Seven of our Marketplace contributors give their analysis and share one top idea. Look for more roundtables and analysis this summer from our community of 180+ Marketpalce services. ~ By Tim Murphy, Ma...

Meridian saw a huge jump in earnings once the pandemic set in. Investors may worry that as the pandemic eases away, those earnings will also fall. I believe that worry is unfounded. For further details see: Meridian Bioscience: Correctly Valued

Wall Street ended an uncertain session with mild losses on Wednesday. The lack of direction came as investors digested new commentary from Federal Reserve Chairman Jerome Powell. While the stock market finished near the unchanged market, many commodities came under serious pressure. This incl...

Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays PR Newswire CINCINNATI , June 20, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing s...

Stocks suffered a setback on Wednesday, losing ground after two days of modest gains. Overall, the major averages continue to show a lack of direction, as investors remain worried about inflation, interest rates and the possibility of an eventual recession. Scotts Miracle-Gro (NYSE:SMG) was a...

Diagnostics and molecular reagents company Meridian Bioscience (NASDAQ:VIVO) hit a 52-week high of $28.93 on Wednesday. As of Wednesday morning, the stock is up 36% year to date. Meridian (VIVO) has benefitted from a strong demand for reagents associated with COVID-19 antigen testin...

Meridian Bioscience (NASDAQ:VIVO) said that its qPCR master mixes can be used to develop molecular diagnostic tests that can detect monkeypox. The company said its inhibitor-tolerant qPCR master mixes are ideal for the detection of monkeypox. Meridian (VIVO) added that qPCR detection is ...

Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests PR Newswire CINCINNATI , May 26, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global pr...

Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference PR Newswire CINCINNATI , May 23, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and ...

Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for ...